You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Pharmacia And Upjohn Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for PHARMACIA AND UPJOHN, and what generic and branded alternatives to PHARMACIA AND UPJOHN drugs are available?

PHARMACIA AND UPJOHN has seventy-two approved drugs.



Summary for Pharmacia And Upjohn
US Patents:0
Tradenames:58
Ingredients:56
NDAs:72
Drug Master File Entries: 41

Drugs and US Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn SOLU-MEDROL methylprednisolone sodium succinate INJECTABLE;INJECTION 011856-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Pharmacia And Upjohn HALOTESTIN fluoxymesterone TABLET;ORAL 010611-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Pharmacia And Upjohn E-MYCIN E erythromycin ethylsuccinate SUSPENSION;ORAL 062198-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Pharmacia And Upjohn FOLEX PFS methotrexate sodium INJECTABLE;INJECTION 081242-001 Aug 23, 1991 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Pharmacia And Upjohn DIZAC diazepam INJECTABLE;INJECTION 019287-001 Jun 18, 1993 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Pharmacia And Upjohn OGEN estropipate CREAM;VAGINAL 084710-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Pharmacia And Upjohn CALMURID HC hydrocortisone; urea CREAM;TOPICAL 083947-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-003 Oct 31, 1988 3,793,457 ⤷  Try a Trial
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-002 Oct 31, 1988 3,793,457 ⤷  Try a Trial
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 3,706,789 ⤷  Try a Trial
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 3,778,506 ⤷  Try a Trial
Pharmacia And Upjohn DIZAC diazepam INJECTABLE;INJECTION 019287-001 Jun 18, 1993 RE32393 ⤷  Try a Trial
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-003 Oct 31, 1988 3,755,427 ⤷  Try a Trial
Pharmacia And Upjohn ANSAID flurbiprofen TABLET;ORAL 018766-002 Oct 31, 1988 3,755,427 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.